Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes

Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes

(2011) Karly C. Sourris et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy

(2010) K. Huynh et al.   DIABETES

Global estimates of the prevalence of diabetes for 2010 and 2030

(2009) J.E. Shaw et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Rodent models of diabetic cardiomyopathy

(2009) H. Bugger et al.   Disease Models & Mechanisms

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League

(2009) Stephan Lüders et al.   JOURNAL OF HYPERTENSION

Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome

(2009) Adarsh Kumar et al.   PHARMACOLOGY & THERAPEUTICS

Hypertension and disrupted blood pressure circadian rhythm in Type 2 diabetic db/db mice

(2008) Wen Su et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Hemodynamic Effects of Fenofibrate and Coenzyme Q10 in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction

(2008) G. T. Chew et al.   DIABETES CARE

Ramipril Improves Oxidative Stress-Related Vascular Endothelial Dysfunction in db/db Mice

(2008) Willmann Liang et al.   Journal of Physiological Sciences

Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats

(2007) Manuela Aragno et al.   ENDOCRINOLOGY